Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001185185-26-001307
Filing Date
2026-04-08
Accepted
2026-04-08 20:00:02
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1714
  Complete submission text file 0001185185-26-001307.txt   3165
Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Issuer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address FRIEDRICH-EBERT-ANLAGE 35-37 FRANKFURT AM MAIN Germany 60327
Business Address
TIAN CHRIS (Reporting) CIK: 0002120903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42526 | Film No.: 26849534